Harry Simeonidis

CIK: 0001831767

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INBS

INTELLIGENT BIO SOLUTIONS INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

INBS
INTELLIGENT BIO SOLUTIONS INC.
Mar 18, 2026
Award(A)
Direct
9.2K shares-
INBS
INTELLIGENT BIO SOLUTIONS INC.
Mar 18, 2026
Award(A)
Direct
21.4K shares-
INBS
INTELLIGENT BIO SOLUTIONS INC.
Sep 25, 2024
Award(A)
Direct
40K shares-

		Type	Shares	Price		Ownership
Mar 18, 2026	INBS INTELLIGENT BIO SOLUTIONS INC.	Award(A)	9,150	-	$0	Direct
Mar 18, 2026	INBS INTELLIGENT BIO SOLUTIONS INC.	Award(A)	21,350	-	$0	Direct
Sep 25, 2024	INBS INTELLIGENT BIO SOLUTIONS INC.	Award(A)	40,000	-	$0	Direct

1-3 of 3 transactions

About Simeonidis Harry

Simeonidis Harry (SEC CIK 0001831767) files insider reports with the SEC as Chief Executive Officer of INTELLIGENT BIO SOLUTIONS INC. (INBS).

Signal8 holds 2 ownership filings by Simeonidis Harry, all Form 4s, filed between Sep 27, 2024 and Mar 20, 2026. Those filings report 3 transactions, from Sep 25, 2024 to Mar 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Simeonidis Harry's filings is in NEW YORK, NY.

Recent filings by Simeonidis Harry

Mar 18, 2026: Grants or awards of INBS shares (2 lines, Form 4, code A).
Sep 25, 2024: Grant or award of INBS shares (Form 4, code A).